1
|
Bremond-Gignac D, Robert M, Daruich A, Borderie V, Chiambaretta F, Valleix S. [National protocol for diagnosis and care of congenital aniridia: Summary for the attending physician]. J Fr Ophtalmol 2022; 45:647-652. [PMID: 35667788 DOI: 10.1016/j.jfo.2022.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Accepted: 01/10/2022] [Indexed: 11/29/2022]
Abstract
Congenital aniridia is a rare panocular disease defined by a national diagnostic and care protocol (PNDS) validated by the HAS. In most cases, it is due to an abnormality in the PAX6 gene, located at 11p13. Aniridia is a potentially blinding autosomal dominant disease with high penetrance. The prevalence varies from 1/40,000 births to 1/96,000 births. Approximately one third of cases are sporadic. Ocular involvement includes complete or partial absence of iris tissue, corneal opacification with neovascularization, glaucoma, cataract, foveal hypoplasia, optic disc hypoplasia and ptosis. These ocular disorders coexist to varying degrees and progress with age. Congenital aniridia manifests in the first months of life as nystagmus, visual impairment and photophobia. A syndromic form such as WAGR syndrome, WAGRO syndrome (due to the risk of renal Wilms tumor) or Gillespie syndrome (cerebellar ataxia) must be ruled out. Systemic associations may include diabetes, due to expression of the PAX6 gene in the pancreas, as well as other extraocular manifestations. Initial assessment is best carried out in a referral center specialized in rare ophthalmologic diseases, with annual follow-up. The management of progressive ocular involvement must be both proactive and responsive, with medical and surgical management. Visual impairment and photophobia result in disability, leading to difficulties in mobility, movement, communication, learning, fine motor skills, and autonomy, with consequences in personal, school, professional, socio-cultural and athletic life. Medico-socio-educational care involves a multidisciplinary team. Disability rehabilitation must be implemented to prevent and limit situations of handicap in activities of daily living, relying on the Commission for the Rights and Autonomy of People with Disabilities (CDAPH) within the Departmental House of People with Disabilities (MDPH). The general practitioner coordinates multidisciplinary medical and paramedical care.
Collapse
Affiliation(s)
- D Bremond-Gignac
- Service d'ophtalmologie, centre hospitalier universitaire Necker-Enfants Malades, AP-HP, université de Paris, 149, rue de Sèvres, 75015 Paris, France; Inserm 1138, T17, université de Paris, Paris, France; OPHTARA, Coordonnateur centre de maladies rares en ophtalmologie (CRMR), Filière Sensgene, centre hospitalier universitaire Necker-Enfants Malades, Paris, France.
| | - M Robert
- Service d'ophtalmologie, centre hospitalier universitaire Necker-Enfants Malades, AP-HP, université de Paris, 149, rue de Sèvres, 75015 Paris, France; OPHTARA, Coordonnateur centre de maladies rares en ophtalmologie (CRMR), Filière Sensgene, centre hospitalier universitaire Necker-Enfants Malades, Paris, France
| | - A Daruich
- Service d'ophtalmologie, centre hospitalier universitaire Necker-Enfants Malades, AP-HP, université de Paris, 149, rue de Sèvres, 75015 Paris, France; Inserm 1138, T17, université de Paris, Paris, France; OPHTARA, Coordonnateur centre de maladies rares en ophtalmologie (CRMR), Filière Sensgene, centre hospitalier universitaire Necker-Enfants Malades, Paris, France
| | - V Borderie
- Ophtalmologie, CHNO des XV-XX, Paris, France
| | - F Chiambaretta
- Ophtalmologie, CHU de Clermont-Ferrand, Clermont-Ferrand, France
| | - S Valleix
- Inserm 1138, T17, université de Paris, Paris, France; Laboratoire de génétique moléculaire, centre hospitalier universitaire Necker-Enfants Malades, AP-HP, université de Paris, Paris, France
| | | |
Collapse
|
2
|
Bourguiba R, Bachmeyer C, Moguelet P, Kaaki S, Ory C, Touchard G, Cattan E, Georgin-Lavialle S, Colombat M, Valleix S. LC-MS/MS and immuno-electron subtyping combined with genetics show that OSMR mutations cause amyloid deposition of keratins 5/14 in familial primary localized cutaneous amyloidosis. J Eur Acad Dermatol Venereol 2021; 36:e66-e68. [PMID: 34459039 DOI: 10.1111/jdv.17630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Accepted: 07/29/2021] [Indexed: 11/27/2022]
Affiliation(s)
- R Bourguiba
- Service de Médecine Interne, Hôpital Tenon, AP-HP, Paris, France
| | - C Bachmeyer
- Service de Médecine Interne, Hôpital Tenon, AP-HP, Paris, France
| | - P Moguelet
- Service d'Anatomo-Pathologie, Hôpital Tenon, AP-HP, Paris, France
| | - S Kaaki
- Service d'Anatomie et Cytologie Pathologique, Unité de Pathologie Ultrastructurale, CHU Poitiers and Centre de Référence Amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, CHU Poitiers, Poitiers, France
| | - C Ory
- Service d'Anatomie et Cytologie Pathologique, Unité de Pathologie Ultrastructurale, CHU Poitiers and Centre de Référence Amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, CHU Poitiers, Poitiers, France
| | - G Touchard
- Service d'Anatomie et Cytologie Pathologique, Unité de Pathologie Ultrastructurale, CHU Poitiers and Centre de Référence Amylose AL et autres maladies à dépôts d'immunoglobulines monoclonales, CHU Poitiers, Poitiers, France
| | - E Cattan
- Cabinet de Dermatologie, Pantin, France
| | | | - M Colombat
- Service d'Anatomie et Cytologie Pathologique, Institut Universitaire du Cancer, CHU Toulouse, Université Paul Sabatier, Toulouse, France
| | - S Valleix
- Laboratoire de Biologie et Génétique Moléculaires, Hôpital Cochin, AP-HP.CUP, Université de Paris, Paris, France
| |
Collapse
|
3
|
Memmi B, Valleix S, Bourcier T, Labetoulle M, Rousseau A. Dystrophie granulaire: pas toujours facile à classifier…. J Fr Ophtalmol 2020; 43:e361-e363. [DOI: 10.1016/j.jfo.2020.02.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 02/20/2020] [Accepted: 02/25/2020] [Indexed: 10/23/2022]
|
4
|
Scafi M, Valleix S, Benyamine A, Jean E, Harlé JR, Rossi P, Daniel L, Schleinitz N, Granel B. L’amylose à lysozyme. Rev Med Interne 2019; 40:323-329. [DOI: 10.1016/j.revmed.2018.08.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Accepted: 08/29/2018] [Indexed: 11/25/2022]
|
5
|
Bremond-Gignac D, Burin des Roziers C, Beugnet C, Fourrage C, Moriniere V, Robert M, Valleix S. Genetic anomalies in congenital cataract. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.03163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
| | | | - C. Beugnet
- Laboratoire de Génétique Moléculaire; Hôpital Necker; Paris France
| | - C. Fourrage
- Laboratoire de Génétique Moléculaire; Hôpital Necker; Paris France
| | - V. Moriniere
- Laboratoire de Génétique Moléculaire; Hôpital Necker; Paris France
| | - M. Robert
- Service d'Ophtalmologie; Hôpital Necker; Paris France
| | - S. Valleix
- Laboratoire de Génétique Moléculaire et INSERM U1163; Hôpital Necker et Institut Imagine; Paris France
| |
Collapse
|
6
|
Bremond-Gignac D, Mincheva Z, DeVergnes N, Valleix S, Robert M. Ophtara centers of expertise in France: Fostering collaborative research and patient care for rare eye diseases. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.0t043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- D. Bremond-Gignac
- Pediatric Ophthalmology; Hôpital Universitaire Necker Enfants Malades-OPHTARA; Paris France
| | - Z. Mincheva
- SENSGENE and OPHTARA Centers; Hôpital Universitaire Necker Enfants Malades; Paris France
| | - N. DeVergnes
- OPHTARA Center; Hôpital Universitaire Necker Enfants Malades; Paris France
| | - S. Valleix
- Molecular Genetics-OPHTARA; Hôpital Universitaire Necker Enfants Malades; Paris France
| | - M. Robert
- Pediatric Ophthalmology; Hôpital Universitaire Necker Enfants Malades-OPHTARA; Paris France
| | | | | |
Collapse
|
7
|
Burin des Roziers C, Rothschild P, Barjol A, Clément C, Edelson C, Derrien S, Metge F, Michau S, Robert M, Prévot C, Dollfus H, Layet V, Delphin N, Bernardelli M, Ghiotti T, Hanein S, Fourrage C, Bonnefont J, Rozet J, Brézin A, Caputo G, Brémond-Gignac D, Valleix S. Targeted NGS: an effective approach for molecular diagnosis of hereditary vitreoretinopathies. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.02361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- C. Burin des Roziers
- Laboratoire de Génétique Ophtalmologique; Institut Imagine - Institut des maladies génétiques; Paris France
| | - P.R. Rothschild
- Département d'ophtalmologie; Groupe Hospitalier Cochin-Hôtel-Dieu; Paris France
| | - A. Barjol
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - C.A. Clément
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - C. Edelson
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - S. Derrien
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - F. Metge
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - S. Michau
- Service d'ophtalmologie; Centre Hospitalier Universitaire de Montpellier; Montpellier France
| | - M. Robert
- Service d'ophtalmologie; Hôpital Necker - Enfants malades; Paris France
| | - C. Prévot
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - H. Dollfus
- Centre Hospitalier Universitaire de Strasbourg; Centre de référence pour les Affections Rares en Génétique Ophtalmologique CARGO; Strasbourg France
| | - V. Layet
- Groupe Hospitalier du Havre; Service de génétique clinique; Le Havre France
| | - N. Delphin
- Service de génétique moléculaire; Hôpital Necker - Enfants malades; Paris France
| | - M. Bernardelli
- Service de génétique moléculaire; Hôpital Necker - Enfants malades; Paris France
| | - T. Ghiotti
- Service de génétique moléculaire; Groupe Hospitalier Cochin-Hôtel-Dieu; Paris France
| | - S. Hanein
- Plateforme de génomique; Institut Imagine - Institut des maladies génétiques; Paris France
| | - C. Fourrage
- Service de génétique moléculaire; Hôpital Necker - Enfants malades; Paris France
| | - J.P. Bonnefont
- Service de génétique moléculaire; Hôpital Necker - Enfants malades; Paris France
| | - J.M. Rozet
- Laboratoire de Génétique Ophtalmologique; Institut Imagine - Institut des maladies génétiques; Paris France
| | - A. Brézin
- Département d'ophtalmologie; Groupe Hospitalier Cochin-Hôtel-Dieu; Paris France
| | - G. Caputo
- Service d'ophtalmologie; Fondation Rothschild; Paris France
| | - D. Brémond-Gignac
- Service d'ophtalmologie; Hôpital Necker - Enfants malades; Paris France
| | - S. Valleix
- Service de génétique moléculaire; Hôpital Necker - Enfants malades; Paris France
| |
Collapse
|
8
|
Bourges J, Burin des Roziers C, Beugnet C, Nedelec B, Hoffart L, Delbosc B, Muraine M, Hamel C, Lacombe D, Moriniere V, Fourrage C, Robert M, Bremond-Gignac D, Valleix S. Update in genetics of corneal dystrophies. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.02661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- J.L. Bourges
- Service d'Ophtalmologie; Hôpital Hôtel-Dieu; Paris France
| | | | - C. Beugnet
- Laboratoire de Génétique Moléculaire; Hôpital Necker; Paris France
| | - B. Nedelec
- INSERM U1163; Institut Imagine; Paris France
| | - L. Hoffart
- Service d'Ophtalmologie; Hôpital de la Timone; Marseille France
| | - B. Delbosc
- Service d'Ophtalmologie; Hôpital Jean Minjoz; Besançon France
| | - M. Muraine
- Service d'OPhtalmologie; CHU de Rouen; Rouen France
| | - C. Hamel
- Neurosciences_INSERM U1051; CHRU de Montpellier; Montpellier France
| | - D. Lacombe
- Génétique; CHU de Bordeaux; Bordeaux France
| | - V. Moriniere
- Laboratoire de Génétique Moléculaire; Hôpital Necker; Paris France
| | - C. Fourrage
- Laboratoire de Génétique Moléculaire; Hôpital Necker; Paris France
| | - M. Robert
- Service d'Ophtalmologie; Hôpital Necker; Paris France
| | | | - S. Valleix
- Laboratoire de Génétique Moléculaire et INSERM U1163; Hôpital Necker et Institut Imagine; Paris France
| |
Collapse
|
9
|
Meyer L, Ulrich M, Ducloux D, Garrigue V, Vigneau C, Boffa J, Clabault K, Mousson C, Nochy D, Vrigneaud L, François H, Valleix S. Caractéristiques génétiques, phénotypiques et évolutives de l’amylose à fibrinogène : une série française. Nephrol Ther 2016. [DOI: 10.1016/j.nephro.2016.07.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Colombat M, Holifanjaniaina S, Onifarasoaniaina S, Valleix S, Maisonneuve H, Kahn JE. [Proteomics, a new tool for an accurate typing of amyloidosis]. Rev Med Interne 2014; 36:346-51. [PMID: 25544147 DOI: 10.1016/j.revmed.2014.11.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2014] [Revised: 10/24/2014] [Accepted: 11/23/2014] [Indexed: 11/28/2022]
Abstract
Amyloidosis is a rare group of diseases related to extracellular deposition of proteins in an insoluble beta-pleated sheet structure presenting a characteristic apple-green birefringence under polarized light after Congo red staining. Thirty types of proteins are known to cause amyloidosis. The accurate identification of the amyloid protein is of paramount importance since it is a key step for the clinical management and personalized treatment. Amyloid typing is usually based on immunohistochemistry and immunofluorescence on tissular sections. This approach has several limits leading to a subtyping failure rate of 15 to 58% of cases. To overcome these difficulties, proteomic methods have been developed to characterize directly the amyloid protein. The most advanced technique carried out on fixed and paraffin-embedded tissue consists of laser microdissection followed by mass spectrometry. The type of amyloidosis can be determined in more than 95% of cases. However, the experience for this technique is very limited apart from the Mayo Clinic (Rochester, United States). In France, a very close proteomic assay has been implemented in the department of pathology of Foch Hospital with similar results. The introduction of proteomics in clinical practice represents a major improvement for typing amyloidosis. In this article, we discuss the benefits and limits of the different techniques used for amyloid classification and we briefly report our proteomic results.
Collapse
Affiliation(s)
- M Colombat
- Service d'anatomie et de cytologie pathologique, hôpital Foch, 92150 Suresnes, France.
| | - S Holifanjaniaina
- Service d'anatomie et de cytologie pathologique, hôpital Foch, 92150 Suresnes, France
| | - S Onifarasoaniaina
- Service d'anatomie et de cytologie pathologique, hôpital Foch, 92150 Suresnes, France
| | - S Valleix
- Laboratoire de biochimie et de génétique moléculaire, hôpital Cochin, 75014 Paris, France
| | - H Maisonneuve
- Service de médecine interne, centre hospitalier départemental Vendée, 85925 La Roche-sur-Yon, France
| | - J E Kahn
- Service de médecine interne, hôpital Foch, 92150 Suresnes, France
| | | |
Collapse
|
11
|
Holifanjaniaina S, Onifarasoaniana S, Valleix S, Leclair F, Dimet S, Colombat M, Guillonneau F, Salnot V, Leduc M. La protéomique, une nouvelle technique pour un typage fiable des amyloses. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
12
|
Bouteau I, Barbet C, Joly D, Machet M, Goujon J, Bremont-Weill C, Valleix S, Touchard G, Halimi J, Bridoux F. Une nouvelle forme de néphropathie amyloïde : l’amylose à la calcitonine. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
13
|
Jean E, Valleix S, Bernard F, Serratrice J, Serratrice C, Disdier P, Weiller PJ, Harle JR, Schleinitz N, Granel B. L’amylose à lysozyme : à propos de cinq familles d’origine piémontaise portant la mutation Trp64Arg. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.316] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
Barjol A, Valleix S, Nedellec B, Ingster Moati I, Tepenier L, Brezin A. 098 Vitréorétinopathie de transmission autosomique dominante : étude du phénotype dans une famille de patients présentant une mutation du gène de la versicane, associée à la maladie de Wagner. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73235-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
15
|
Magy-Bertrand N, Méaux-Ruault N, Hafsaoui C, Valleix S, Cunat S, Salard D, Gil H, Kantelip B. Élastorrhexie, macroglossie et infiltration salivaire massive : 3nouvelles manifestations de l’amylose héréditaire à transthyrétine (Tyr78Phe). Rev Med Interne 2008. [DOI: 10.1016/j.revmed.2008.10.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
16
|
Grateau G, Valleix S, Callard P. [Multisystemic amyloidosis in 2007]. Rev Med Interne 2007; 28:281-3. [PMID: 17291633 DOI: 10.1016/j.revmed.2007.01.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2006] [Revised: 01/01/2007] [Accepted: 01/08/2007] [Indexed: 11/21/2022]
|
17
|
Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S. Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 2001; 57:135-7. [PMID: 11445644 DOI: 10.1212/wnl.57.1.135] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
CNS involvement is rare in systemic amyloidoses due to transthyretin (TTR) mutation and manifests as a combination of dementia, seizures, and myelopathy. The authors report two French siblings who experienced recurrent subarachnoid hemorrhages as the main clinical feature. Brain specimens showed that the leptomeningeal vessels walls were thickened by amyloid deposits, and sequencing of the TTR exons showed a heterozygous single base-pair transition from G to A (codon 53), resulting in a glycine for glutamic acid substitution (G53E).
Collapse
Affiliation(s)
- E Ellie
- Service de Neurologie, Centre Hospitalier de la Côte Basque, Bayonne, France.
| | | | | | | | | | | | | |
Collapse
|
18
|
Valleix S, Drunat S, Philit J, Adoue D, Piette J, Droz D, Mac Gregor B, Canet D, Delpech M, Grateau G. Amylose rénale héréditaire associée à une nouvelle mutation (W64R) du lysozyme. Rev Med Interne 2001. [DOI: 10.1016/s0248-8663(01)83407-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Affiliation(s)
- G Grateau
- Service de médecine interne, Hôtel-Dieu, Assistance publique-hôpitaux de Paris, 1, place du parvis Notre-Dame, 75181 Paris
| | | | | |
Collapse
|
20
|
Magy N, Valleix S, Grateau G, Algros M, Gil H, Kantelip B, Dupond J. Amylose familiale : une nouvelle famille porteuse de la mutation (alanine 47) de la transthyrétine. Rev Med Interne 2001. [DOI: 10.1016/s0248-8663(01)83341-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
21
|
Dighiero P, Niel F, Ellies P, D'Hermies F, Savoldelli M, Renard G, Delpech M, Valleix S. Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the TGFBI gene. Ophthalmology 2001; 108:818-23. [PMID: 11297504 DOI: 10.1016/s0161-6420(00)00662-x] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
PURPOSE To establish a phenotype-genotype correlation of various autosomal-dominant corneal dystrophies among French subjects. DESIGN Retrospective molecular genetic study and clinicopathologic correlation. PARTICIPANTS Forty-four subjects from 26 unrelated French families were included in this study, and 60 corneal buttons could be examined at the histologic and ultrastructural levels. METHODS Light microscopy and transmission electron microscopy were performed on corneal specimens obtained during keratoplasty. Blood samples were collected for DNA analysis. MAIN OUTCOME MEASURES After genomic DNA extraction from peripheral blood leukocytes of each family member, exons of the TGFBI gene were amplified by polymerase chain reaction (PCR), and the PCR products were directly sequenced on both strands. RESULTS Four different mutations were found to be responsible for dystrophy of granular type (R555W, R124L, R124H, and R124L+delT125-delE126), three other different mutations produced a lattice type (R124C, H626R, and A546T), and the last mutation identified was associated with the honeycomb-shaped dystrophy (R555Q). Each subtype of dystrophy showed, histologically and ultrastructurally, specific characteristics that are easily recognizable. However, besides these stereotyped forms, differential histologic diagnosis of atypical forms remains difficult, and these forms could be misdiagnosed. CONCLUSIONS The characteristic biomicroscopic appearance and histopathologic features of each "classic" dystrophy present a significant degree of specificity and generally provide an accurate diagnosis. However, atypical forms in which clinical and histologic data alone could be misleading, are unequivocally diagnosed after DNA analysis.
Collapse
Affiliation(s)
- P Dighiero
- Department of Ophthalmology, Hôtel-Dieu Hospital, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Favier R, Lavergne JM, Costa JM, Caron C, Mazurier C, Viémont M, Delpech M, Valleix S. Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female. Blood 2000; 96:4373-5. [PMID: 11110718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023] Open
Abstract
This report is of a 14-month-old girl affected with severe hemophilia A. Both her parents had normal values for factor VIII activity, and von Willebrand disease type 2N was excluded. Karyotype analysis demonstrated no obvious alteration, and BclI Southern blot did not reveal F8 gene inversions. Direct sequencing of F8 gene exons revealed a frameshift-stop mutation (Q565delC/ter566) in the heterozygous state in the proposita only. F8 gene polymorphism analysis indicated that the mutation must have occurred de novo in the paternal germline. Furthermore, analysis of the pattern of X chromosome methylation at the human androgen receptor gene locus demonstrated a skewed inactivation of the derived maternal X chromosome from the lymphocytes of the proband's DNA. Thus, the severe hemophilia A in the proposita results from a de novo F8 gene frameshift-stop mutation on the paternally derived X chromosome, associated with a nonrandom pattern of inactivation of the maternally derived X chromosome. (Blood. 2000;96:4373-4375)
Collapse
Affiliation(s)
- R Favier
- Service d'Hématologie Biologique, Hôpital d'Enfants Armand Trousseau, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Dighiero P, Ellies P, Valleix S, D'hermies F, Savoldelli M, Pouliquen Y, Legeais JM, Renard G. [Avellino dystrophy. Current diagnostic criteria]. J Fr Ophtalmol 2000; 23:735-7. [PMID: 10992072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
We report a French family suffering from an Avellino corneal dystrophy diagnosed by using clinical, histological, ultrastructural and genetics findings. Our results indicate that direct corneal examination and routine histological examinations must always be associated with an assay for BIGH3 gene mutations to establish a modern and unambiguous diagnosis of a corneal dystrophy.
Collapse
Affiliation(s)
- P Dighiero
- Service d'Ophtalmologie, Hôtel Dieu, 1, place du Parvis Notre-Dame, F-75181 Paris cedex 04, France
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Dighiero P, Valleix S, D'Hermies F, Drunat S, Ellies P, Savoldelli M, Pouliquen Y, Delpech M, Legeais JM, Renard G. Clinical, histologic, and ultrastructural features of the corneal dystrophy caused by the R124L mutation of the BIGH3 gene. Ophthalmology 2000; 107:1353-7. [PMID: 10889112 DOI: 10.1016/s0161-6420(00)00149-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
OBJECTIVE This study was designed to describe the clinical, histologic, and ultrastructural features of the corneal dystrophy associated with the R124L mutation of the BIGH3 gene. DESIGN Retrospective clinical and histologic review of a new genetic mutation. PARTICIPANTS Thirty-four patients from five unrelated French families with corneal dystrophy caused by the R124L mutation of the BIGH3 gene were studied at the clinical, histologic, and ultrastructural levels. Records of patients carrying this mutation were compared with those from three unrelated patients with corneal dystrophy of Bowman's layer (CDB) type 2 (R555Q mutation) and from three unrelated patients with classic corneal granular dystrophy (R555W mutation). INTERVENTION The mutational genetic status of the BIGH3 gene was determined for each patient, and the histologic and ultrastructural data available after corneal graft were analyzed. MAIN OUTCOMES MEASURES Genomic DNA was extracted from peripheral blood leukocytes. Exons 4 and 12 of the BIGH3 gene were amplified by the polymerase chain reaction (PCR), and the PCR products were directly sequenced. RESULTS All 34 patients with the R124L mutation displayed the clinical, histologic, and electron microscopic features of the dystrophy previously described as a superficial variant of corneal granular dystrophy. Combining molecular genetics with clinical and histologic findings established a clear distinction between the R555Q and R555W dystrophies. CONCLUSIONS The R124L mutation of the BIGH3 gene is associated with specific clinical and morphologic criteria. This indicates that molecular studies are needed for an adequate classification of corneal dystrophies. All criteria are presently available to segregate the dystrophy caused by the R124L mutation (known as CDB1) from the dystrophy caused by the R555Q mutation (known as CDB2).
Collapse
Affiliation(s)
- P Dighiero
- Department of Ophthalmology, Hotel-Dieu de Paris, Paris, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Abstract
INTRODUCTION The diagnosis of amyloidosis is a four-step strategy requiring: 1) a high degree of suspicion, as the clinical presentation of the disease is very polymorphous; 2) the biochemical nature of the disease; 3) the evaluation of the disease spread and 4) how it evolves. EXEGESIS Simple and noninvasive biopsies usually make it possible to diagnose amyloidosis. Available treatments of generalized amyloidosis require an exact characterization of the nature of amyloid deposits, which is based on the clinical context, immunohistochemical analysis of amyloid deposits, and genetic testing. CONCLUSION Management of amyloidosis should be improved by better characterization of amyloid deposits. This would result in epidemiological data which are currently lacking.
Collapse
Affiliation(s)
- G Grateau
- Service de médecine interne, L'Hôtel-Dieu de Paris, France
| | | | | | | | | | | |
Collapse
|
26
|
Dighiero P, Drunat S, D'Hermies F, Renard G, Delpech M, Valleix S. A novel variant of granular corneal dystrophy caused by association of 2 mutations in the TGFBI gene-R124L and DeltaT125-DeltaE126. Arch Ophthalmol 2000; 118:814-8. [PMID: 10865320 DOI: 10.1001/archopht.118.6.814] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
OBJECTIVE To characterize the molecular defect in the TGFBI gene in a French family affected with an atypical granular corneal dystrophy. PATIENTS This family comprises 9 affected individuals across 3 generations without consanguineous marriage. METHODS Light and electron microscopy were used to examine corneal buttons from patients. Exons of the TGFBI gene were amplified by polymerase chain reaction and sequenced directly using an automated method. Restriction digestion analysis and heteroduplex screening were performed to confirm that the mutations identified were not polymorphisms. RESULTS Round or snow-flakes-like deposits that stained red with Masson trichrome and appeared as dense, rod-shaped structures were observed in the most anterior layers of the central stroma. All patients were heterozygous for the R124L mutation and a novel mutation predicting the deletion of 2 amino acid residues-threonine (T) and glutamic acid (E)-at codons 125 and 126. CONCLUSIONS This French family is affected with a novel variant of granular dystrophy that is caused by a molecular defect in the TGFBI gene, reported here for the first time. CLINICAL RELEVANCE These 2 mutations cause a novel variant of granular dystrophy that is intermediate in severity between the classical and superficial variant forms. Arch Ophthalmol. 2000;118:814-818
Collapse
Affiliation(s)
- P Dighiero
- Laboratoire de Biochimie et Génétique Moléculaire, 123 boulevard du Port-Royal, 75014 Paris, France
| | | | | | | | | | | |
Collapse
|
27
|
Dighiero P, Drunat S, Ellies P, D'Hermies F, Savoldelli M, Legeais JM, Renard G, Delpech M, Grateau G, Valleix S. A new mutation (A546T) of the betaig-h3 gene responsible for a French lattice corneal dystrophy type IIIA. Am J Ophthalmol 2000; 129:248-51. [PMID: 10682981 DOI: 10.1016/s0002-9394(99)00324-4] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
PURPOSE To characterize the betaig-h3 gene defect in a French family affected with lattice corneal dystrophy type IIIA (LCDIIIA). METHODS Histologic examination was performed from corneal buttons of two patients. Genomic DNA was extracted from leukocytes, and exons of the betaig-h3 gene were amplified by polymerase chain reaction to be directly sequenced. RESULTS Numerous deposits were evident in the stroma and beneath the Bowman membrane, which had all the features of amyloid deposits. Analysis of exon 12 revealed a heterozygous G to A transition on codon 546. CONCLUSION In contrast to Japanese patients, these French patients affected with LCDIIIA carry a distinct mutation of the betaig-h3 gene (A546T instead of P501T). Therefore, it is unclear whether different mutations could result in the same dystrophy or whether we are dealing with clinical heterogeneity of LCDIIIA.
Collapse
Affiliation(s)
- P Dighiero
- Laboratoire de Biochimie et Génétique Moléculaire, the Department of Ophthalmology, Hôtel-Dieu, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Valleix S, Jeanny JC, Elsevier S, Joshi RL, Fayet P, Bucchini D, Delpech M. Expression of human F8B, a gene nested within the coagulation factor VIII gene, produces multiple eye defects and developmental alterations in chimeric and transgenic mice. Hum Mol Genet 1999; 8:1291-301. [PMID: 10369875 DOI: 10.1093/hmg/8.7.1291] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Factor VIII-associated gene B ( F8B ) is a small human gene of unknown function which is nested within the gene encoding coagulation factor VIII ( FVIII ) in chromosome band Xq28. The sequence of F8B includes the C2 cell adhesion motif of factor VIII, which has also been identified in numerous proteins known to play important roles during development. Here we have constructed both chimeric and transgenic mice expressing normal human F8B to investigate its possible developmental effects. The chimeras produced from embryonic stem cells transfected with normal F8B under control of a cytomegalovirus promoter and selected for neomycin resistance expressed readily detectable levels of F8B mRNA in multiple tissues. They showed growth retardation, microcephaly, reduced longevity and severe ocular defects, and although they were fertile, gave birth to no F8B heterozygous pups. Seven transgenic mouse lines, produced by injection of the transgene into fertilized oocytes, were viable and of normal size but expressed lower levels of F8B mRNA. Strikingly, they showed the same severe eye abnormalities as the chimeras. These defects included anterior segment dysgenesis, absent or abnormal lens, persistence of the primary vitreous, Harderian gland tumors and ectopic pigmented cells, suggesting that migration of neural crest cells might have been perturbed during eye development. In addition, dysplastic retinas and the absence of photoreceptors were observed, providing a mouse model for retinal degeneration.
Collapse
Affiliation(s)
- S Valleix
- Laboratoire de Biologie Moléculaire des Cellules Eucaryotes EA 1501, INSERM U257, Université Paris V, Faculté de Médecine Cochin-Port-Royal, Paris, France
| | | | | | | | | | | | | |
Collapse
|
29
|
Valleix S, Nafa K, Stieltjes N, Viemont M, Sultan Y, Kaplan JC, Delpech M. Prevalence, male germ-line origin and new patterns of inversions in haemophilia A. Ann Genet 1997; 40:35-40. [PMID: 9150848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Following the discovery of the FVIII gene inversion by Lakich et al. [1] and Naylor et al. [2], we have investigated this mutation in 108 French and Algerian severe haemophilia A patients. We have found that only 29 severe haemophiliacs (27%) exhibited the rearrangement whereas Lakich et al. [1] and Naylor et al. [2] respectively estimated the inversion frequency at 47% and 42% in severe haemophiliacs. The reason for this discrepancy is not accounted for. In this study, we observed two novel patterns of inversions as yet unreported. We did not find any correlation between the presence of the inversion and a particular RLFP haplotype, or ethnic origin, or the absence of a FVIII inhibitor. Among the cases with the inversion, the proportion of sporadic and transmitted cases was roughly equivalent and we also confirm that the inversion occurs preferentially in the male germ-line.
Collapse
Affiliation(s)
- S Valleix
- Institut Cochin, Université Paris V, France
| | | | | | | | | | | | | |
Collapse
|
30
|
Amselem S, Duquesnoy P, Duriez B, Dastot F, Sobrier ML, Valleix S, Goossens M. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum Mol Genet 1993; 2:355-9. [PMID: 8504296 DOI: 10.1093/hmg/2.4.355] [Citation(s) in RCA: 74] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Laron syndrome is a rare autosomal recessive disorder characterized by resistance to growth hormone (GH). In 10 patients of different ethnic origins, we have analyzed all the GH receptor (GHR)-coding exons along with their splice junctions and 6 intragenic polymorphic sites defining several GHR gene haplotypes. This allowed us to identify the mutations in the 20 chromosomes studied and to describe a new GHR haplotype. Eleven different mutations associated with various GHR haplotypes were observed; they included 3 nonsense mutations, 3 splice defects and 5 missense mutations. Of the 11 mutations, 8 were novel. All the mutations involved the exoplasmic domain of the receptor and all the missense mutations were clustered in a short polypeptide segment. Most of the missense mutations affected residues conserved among GHRs from different species and the related molecules that belong to the cytokine receptor superfamily. Adding to the 5 mutations so far described, these findings illustrate the allelic heterogeneity of this syndrome and document the independent origin of the molecular defects, all features of clinical relevance for genetic counselling.
Collapse
Affiliation(s)
- S Amselem
- Laboratoire de Génétique Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM) U.91, Hôpital Henri Mondor, Créteil, France
| | | | | | | | | | | | | |
Collapse
|